Status:
COMPLETED
Impact Of Different Ablation Approaches on Outcome In Coexistent Atrial Fibrillation and Flutter
Lead Sponsor:
Texas Cardiac Arrhythmia Research Foundation
Collaborating Sponsors:
Monzino Hospital, Milan, Italy
Ospedale dell'Angelo, Venezia-Mestre
Conditions:
Atrial Arrhythmia
Quality of Life
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
This prospective, multi-center, single blinded study aims to compare the influence of two different catheter ablation strategies, on long-term ablation outcome in terms of AF recurrence and quality of...
Detailed Description
Specific Aim: This prospective single blinded study aims to compare the influence of two different catheter ablation strategies, on long-term ablation outcome in terms of AF recurrence and quality of ...
Eligibility Criteria
Inclusion
- Age: ≥ 18years
- Patients presenting with paroxysmal AF and typical AFL
- Ability to provide written, informed consent
Exclusion
- Reversible causes of atrial arrhythmia such as hyperthyroidism, pneumonia, pulmonary embolism, sarcoidosis and excessive alcohol consumption
- Bleeding disorder
- Contra-indication to anti-coagulants
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2016
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT01439386
Start Date
September 1 2011
End Date
July 1 2016
Last Update
October 19 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Texas Cardiac Arrhythmia Institute, St. David's Medical Center
Austin, Texas, United States, 78705